CTVA

Corteva, Inc.

Fundamental data last updated:September 24, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Agricultural Inputs

Exchange

NYSE

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.

 


Analyze CTVA on TradingView

VALUATION

P/E

50.00

Market Cap ($M USD)

$57.78B

Forward P/E

16.34

PEG

0.08

PRICE TO SALES

3.23

PRICE TO BOOK

2.38

EV / EBITDA

18.75

5-Year Average P/E

Free Cash Flow Yield

3.54%

DCF Value

$73.33

Graham Number

$37.53

Price to FCF

28.24

EV to FCF

28.83

Earnings Yield

2.00%

FCF Yield

3.54%

DIVIDEND

Yield

0.83%

Annual Payout

$0.72

Payout Ratio

41.31%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$1.73

Next Year EPS Growth Estimate

$5.29

Next Year Revenue Growth Estimate

$19.74B

Return on Equity (ROE)

4.67%

FREE CASH FLOW

Operating Margin

16.26%

Debt-to-Equity

0.11

Piotroski F-Score

9

Altman Z-Score

2.64

Return on Invested Capital (ROIC)

9.43%

Current Ratio

1.47

Quick Ratio

1.03

Net Debt to EBITDA

0.39

Interest Coverage

16.16

Gross Profit margin

46.81%

FCF PER SHARE

$3.04

REVENUE PER SHARE

$26.60

Analyze CTVA on TradingView

Gainseekers Quantitative Analysis

Summary

Corteva, Inc. appears to be a mixed bag when it comes to valuation and financial health. The market has priced it above its DCF value, suggesting potential overvaluation, yet its Forward P/E of 15.61 indicates a more reasonable future outlook. The Altman Z-score of 2.56 suggests moderate financial stability, while the Earnings Yield of 2.13% is underwhelming, hinting at limited immediate returns. Despite these concerns, the company’s robust Piotroski F-Score of 9 signals strong operational efficiency and financial health, making it a complex case for investors.

AI Exposure / Tech Reliance

In the realm of agricultural inputs, Corteva is well-positioned to leverage AI and modern technology to enhance crop yields and optimize supply chains. The industry's increasing reliance on precision agriculture and data analytics plays to Corteva's strengths. As a leader in this space, the company can harness these technologies to maintain a competitive edge.

The Bull Case

For the value or GARP investor, Corteva offers compelling reasons to buy. The company boasts a solid ROIC of 9.43%, indicating efficient use of capital to generate returns. Its Piotroski F-Score of 9 reflects strong financial health, while a healthy operating margin of 16.26% underscores its pricing power. Additionally, a reasonable FCF Yield of 3.77% suggests that the company is generating adequate free cash flow relative to its market cap, making it an attractive proposition for those seeking growth at a reasonable price.

The Bear Case

Despite its strengths, Corteva is not without risks. The Price/Book ratio of 2.24 and Price/Sales ratio of 3.03 suggest that the stock may be overvalued relative to its assets and revenue. The stock's proximity to its 52-week high, just 5.55% away, indicates potential overextension. Furthermore, the Earnings Yield of 2.13% is lackluster, raising questions about the stock's ability to deliver immediate value to shareholders. These factors could pose challenges for investors seeking immediate returns.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$90.88

Institutional Ownership %

1-Year Beta

0.56

Insider Buying % (6 Mo)

Distance to 52-Week High

0.14%

Distance to 52-Week Low

29.93%

EARNINGS SURPRISE %

28.21%

50-DAY SMA

$79.75

200-DAY SMA

$73.21

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.